Dementias pp 195-221 | Cite as

Neuropsychiatric Symptoms in Dementia Patients

  • S. T. Chen
  • J. L. Cummings


Neuropsychiatric symptoms and alterations are common and diverse in scope in the dementias. Alzheimer’s disease (AD) is associated with agitation, psychosis, personality changes, and depression [1, 2, 3, 4, 5, 6]. Vascular dementia (VaD) is accompanied by apathy, depression, and lability [7, 8, 9]. Frontotemporal dementias (FTD) produce apathy, euphoria, irritability, and disinhibition [7, 8, 9, 10]. Depression and anxiety are associated with Parkinson’s disease (PD) patients [11, 12]. Mood changes, personality changes, and psychosis are observed in Huntington’s disease (HD) [13].


Neuropsychiatric Symptom Dementia Patient Senile Dementia Geriatr Psychiatry Demented Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Burns A, Jacoby R, Levy R (1990) Psychiatric phenomena in Alzheimer’s disease. I. Disorders of thought content. Br J Psychiatry 157: 72–76PubMedCrossRefGoogle Scholar
  2. 2.
    Burns A, Jacoby R, Levy R (1990) Psychiatric phenomena in Alzheimer’s disease. II. Disorders of perception. Br J Psychiatry 157: 76–81PubMedCrossRefGoogle Scholar
  3. 3.
    Burns A, Jacoby R, Levy R (1990) Psychiatric phenomena in Alzheimer’s disease. III. Disorders of mood. Br J Psychiatry 157: 81–86PubMedCrossRefGoogle Scholar
  4. 4.
    Burns A, Jacoby R, Levy R (1990) Psychiatric phenomena in Alzheimer’s disease. IV. Disorders of behaviour. Br J Psychiatry 157: 86–94PubMedCrossRefGoogle Scholar
  5. 5.
    Cummings JL, Victoroff JI (1990) Noncognitive neuropsychiatric syndromes in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol 3: 140–158Google Scholar
  6. 6.
    Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A (1987) Behavioral symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry 48[Suppl 5]: 9–15PubMedGoogle Scholar
  7. 7.
    Cummings JL, Benson DF (1992) Dementia: a clinical approach, 2nd edn. Butterworth-Heinemann, BostonGoogle Scholar
  8. 8.
    Cummings JL, Miller B, Hill MA, Neshkes R (1987) Neuropsychiatric aspects of multiinfarct dementia and dementia of the Alzheimer type. Arch Neurol 44: 389–393PubMedCrossRefGoogle Scholar
  9. 9.
    Dian L, Cummings JL, Petry S, Hill MA (1990) Personality alterations in multi-infarct dementia. Psychosomatics 31: 415–419PubMedCrossRefGoogle Scholar
  10. 10.
    Miller BL, Cummings JL, Villanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, Mena I (1991) Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 41: 1374–1382PubMedCrossRefGoogle Scholar
  11. 11.
    Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149: 443–453PubMedGoogle Scholar
  12. 12.
    Stein MB, Heuser IJ, Juncos JL, Uhde TW (1990) Anxiety disorders in patients with Parkinson’s disease. Am J Psychiatry 147: 217–220PubMedGoogle Scholar
  13. 13.
    Mendez MF (1994) Huntington’s disease: update and review of neuropsychiatrie aspects. Int J Psychiatry Med 24: 189–208PubMedCrossRefGoogle Scholar
  14. 14.
    Lesser IM, Miller BL, Boone KB, Hill-Gutierrez E, Mena I (1989) Psychosis as the first manifestation of degenerative dementia. Bull Clin Neurose 54: 59–63Google Scholar
  15. 15.
    Petry S, Cummings JL, Hill MA, Shapira J (1988) Personality alterations in dementia of the Alzheimer type. Arch Neurol 45: 1187–1190PubMedCrossRefGoogle Scholar
  16. 16.
    Rubin EH, Kinscherf DA (1989) Psychopathology of very mild dementia of the Alzheimer type. Am J Psychiatry 146: 1017–1021PubMedGoogle Scholar
  17. 17.
    Petry S, Cummings JL, Hill MA, Shapira J (1989) Personality alterations in dementia of the Alzheimer type: a three-year follow-up study. J Geriatr Psychiatry Neurol 4: 203–207CrossRefGoogle Scholar
  18. 18.
    Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF (1991) Psychosis and physical aggression in probable Alzheimer’s disease. Am J Psychiatry 148: 1159–1163PubMedGoogle Scholar
  19. 19.
    Morriss RK, Rovner BW, Folstein MF, German PS (1990) Delusions in newly admitted residents of nursing homes. Am J Psychiatry 147: 299–302PubMedGoogle Scholar
  20. 20.
    Steele C, Rovner B, Chase GA, Folstein M (1990) Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry 147: 1049–1051PubMedGoogle Scholar
  21. 21.
    Schneider LS, Pollock EE, Lyness SA (1990) A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 38: 553–563PubMedGoogle Scholar
  22. 22.
    Tariot PN, Schneider LS, Katz IR (1995) Anticonvulsant and other non-neuroleptic treatment of agitation in dementia. J Geriatr Psychiatry Neurol 8[Suppl 1]: S28–S39PubMedCrossRefGoogle Scholar
  23. 23.
    Drevets WC, Rubin EH (1989) Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 25: 39–48PubMedCrossRefGoogle Scholar
  24. 24.
    Mortimer JA, Ebbitt B, Jun S-P, Finch MD (1992) Predictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology 42: 1689–1696PubMedCrossRefGoogle Scholar
  25. 25.
    Rosen J, Zubenko GS (1991) Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer’s disease. Biol Psychiatry 29: 224–232PubMedCrossRefGoogle Scholar
  26. 26.
    Stern Y, Mayeux R, Sano M, Hauser WA, Bush T (1987) Predictors of disease course in patients with probable Alzheimer’s disease. Neurology 37: 1649–1653PubMedCrossRefGoogle Scholar
  27. 27.
    Folstein M, Folstein S, McHugh P (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198PubMedCrossRefGoogle Scholar
  28. 28.
    Levin HS, High WM, Goethe KE, Sisson RA, Overall JE, Rhoades HM, Eisenberg HM, Kalisky Z, Gary HE (1987) The neurobehavior rating scale: assessment of the sequelae of head injury by the clinician. J Neurol Neurosurg Psychiatry 50: 183–193PubMedCrossRefGoogle Scholar
  29. 29.
    Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308–2314PubMedCrossRefGoogle Scholar
  30. 30.
    Reisberg B, Franssen E, Sclan S, Kluger A, Ferris SH (1989) Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer disease: a study of 120 patients using the BEHAVE-AD. Bull Clin Neurosci 54: 95–112Google Scholar
  31. 31.
    Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL (1992) Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Geriatr Soc 40: 549–555PubMedGoogle Scholar
  32. 32.
    Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL (1993) A comparison of psychiatric symptoms in vascular dementia and Alzheimer’s disease. Am J Psychiatry 150: 1806–1812PubMedGoogle Scholar
  33. 33.
    Levy ML, Miller BL, Cummings JL, Fairbanks LA, Craig A (1996) Alzheimer disease and frontotemporal dementias: behavioral distinctions. Arch Neurol 53: 687–690PubMedCrossRefGoogle Scholar
  34. 34.
    Litvan I, Mega MS, Cummings JL, Fairbanks L (1996) Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 47: 1184–1189PubMedCrossRefGoogle Scholar
  35. 35.
    Forsell Y, Jorm AF, Winblad B (1993) Variation in psychiatric and behavioural symptoms at different stages of dementia: data from physicians’ examinations and informants’ reports. Dementia 4: 282–286PubMedGoogle Scholar
  36. 36.
    Birkett DP (1972) The psychiatric differentiation of senility and arteriosclerosis. Br J Psychiatry 120: 321–325PubMedCrossRefGoogle Scholar
  37. 37.
    Leuchter AF, Spar JE (1985) The late-onset psychoses. J New Ment Disord 173: 488–494CrossRefGoogle Scholar
  38. 38.
    Wragg RE, Jeste DV (1989) Overview of depression and psychosis in Alzheimer’s disease. Am Psychiatry 146: 577–587Google Scholar
  39. 39.
    Berrios GE, Brook P (1985) Delusions and the psychopathology of the elderly with dementia. Acta Psychiatr Scand 72: 296–301PubMedCrossRefGoogle Scholar
  40. 40.
    Teri L, Larson EB, Reifler BV (1988) Behavioral disturbance in dementia of the Alzheimer’s type. J Am Geriatr Soc 36: 1–6PubMedGoogle Scholar
  41. 41.
    Swearer JM, Drachman DA, O’Donnell BF, Mitchell AL (1988) Troublesome and disruptive behaviors in dementia. J Am Geriatr Soc 36: 784–790PubMedGoogle Scholar
  42. 42.
    Cooper JK, Mungas D, Weiler PG (1990) Relation of cognitive status and abnormal behaviors in Alzheimer’s disease. J Am Geriatr Soc 38: 867–870PubMedGoogle Scholar
  43. 43.
    Flynn FG, Cummings JL, Gornbein J (1991) Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates. J Neuropsychiatry Clin Neurosci 3: 364–370PubMedGoogle Scholar
  44. 44.
    Merriam AE, Aronson MD, Gaston P, Wey SL, Katz I (1988) The psychiatric symptoms of Alzheimer’s disease. J Am Geriatr Soc 36: 7–12PubMedGoogle Scholar
  45. 45.
    Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thal LJ (1992) Cognitive deficits of patients with Alzheimer’s disease with and without delusions. Am J Psychiatry 149: 184–189PubMedGoogle Scholar
  46. 46.
    Doody RS, Massman P, Mahurin R, Law S (1995) Positive and negative neuropsychiatric features in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 7: 54–60PubMedGoogle Scholar
  47. 47.
    Naimark D, Jackson E, Rockwell E, Jeste DV (1996) Psychotic symptoms in Parkinson’s disease patients with dementia. J Am Geriatr Soc 44: 296–299PubMedGoogle Scholar
  48. 48.
    Drachman DA, O’Donnell BF, Lew RA, Swearer JM (1990) The prognosis in Alzheimer’s disease. “How far” rather than “how fast” best predicts the course. Arch Neurol 47: 851–856PubMedCrossRefGoogle Scholar
  49. 49.
    Jagust WJ, Budinger TF, Reed BR (1987) The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 44: 258–262PubMedCrossRefGoogle Scholar
  50. 50.
    Woods SW, Pearsall HR, Scibyl JP, Hoffer PB (1991) The Quinn Essay: single-photon emission computed tomography in neuropsychiatric disorders. In: Hoffer PB (ed) Yearbook of nuclear medicine. Mosby Year Book, St LouisGoogle Scholar
  51. 51.
    Smith GS, de Leon MJ, George AE, Kluger A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Ciaravino J (1992) Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer’s disease: pathophysiologic implications. Arch Neurol 49: 1142–1150PubMedCrossRefGoogle Scholar
  52. 52.
    Grady CL, Haxby JV, Schapiro MB, Gonzalez-Aviles A, Kumar A, Ball MJ, Heston L, Rapoport SI (1990) Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J Neuropsychiatry Clin Neurosci 2: 373–384PubMedGoogle Scholar
  53. 53.
    Sultzer DL, Mahler ME, Mandelkern MA, Cummings JL, Van Gorp WG, Hinkin CH, Berisford MA (1995) The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 7: 476–484PubMedGoogle Scholar
  54. 54.
    Kotrla KJ, Chacko RC, Harper G, Jhingran S, Doody R (1995) SPECT findings on psychosis in Alzheimer’s disease. Am J Psychiatry 152: 1470–1475PubMedGoogle Scholar
  55. 55.
    Starkstein SE, Vazquez S, Petracca G, Sabe L, Migliorelli R, Teson A, Leiguarda R (1994) A SPECT study of delusions in Alzheimer’s disease. Neurology 44: 2055–2059PubMedCrossRefGoogle Scholar
  56. 56.
    Zubenko GS, Moossy J, Martinez AJ, Rao G, Claassen D, Rosen J, Kopp U (1991) Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 48: 619–624PubMedCrossRefGoogle Scholar
  57. 57.
    Cummings JL, Gorman DG, Shapira J (1993) Physostigmine ameliorates the delusions of Alzheimer’s disease. Biol Psychiatry 33: 536–541PubMedCrossRefGoogle Scholar
  58. 58.
    Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50: 743–755PubMedCrossRefGoogle Scholar
  59. 59.
    McKeith IG, Perry RH, Fairbairn SJ, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of the Lewy body type (SDLT). Psychol Med 22: 911–922PubMedCrossRefGoogle Scholar
  60. 60.
    Roberts JK, Trimble MR, Robertson M (1983) Schizophrenic psychosis associated with aqueduct stenosis in adults. J Neurol Neurosurg Psychiatry 46: 892–898PubMedCrossRefGoogle Scholar
  61. 61.
    Mendez MF, Martin RJ, Smyth KA, Whitehouse PJ (1990) Psychiatric symptoms associated with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 2: 28–33PubMedGoogle Scholar
  62. 62.
    Mega MS, Cummings JL, Fiorello T, Gornbein J (1996) The spectrum of behavioral changes in Alzheimer’s disease. Neurology 46: 130–135PubMedCrossRefGoogle Scholar
  63. 63.
    Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH (1990) Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 55: 1454–1456PubMedCrossRefGoogle Scholar
  64. 64.
    Cummings JL (1991) Behavioral complications of drug treatment of Parkinson’s disease. J Am Geriatr Soc 39: 708–716PubMedGoogle Scholar
  65. 65.
    Goetz CG, Tanner CM, Klawans HL (1982) Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry 139: 494–497PubMedGoogle Scholar
  66. 66.
    Devanand DP, Sackeim HA, Brown RP, Mayeux R (1989) A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer’s disease. Arch Neurology 46: 854–857CrossRefGoogle Scholar
  67. 67.
    Devanand DP, Levy SR (1995) Neuroleptic treatment of agitation and psychosis in dementia. J Geriatr Psychiatry Neurol 8[Suppl 1]: S18–S27PubMedCrossRefGoogle Scholar
  68. 68.
    Barnes R, Veith R, Okimoto J, Raskind M, Gumbrecht G (1982) Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am J Psychiatry 139: 1170–1174PubMedGoogle Scholar
  69. 69.
    Carlyle W, Ancill RJ, Sheldon L (1993) Aggression in the demented patient: a doubleblind study of loxapine versus haloperidol. Int Clin Psychopharmacol 8: 103–108PubMedCrossRefGoogle Scholar
  70. 70.
    Cowley LM, Glen RS (1979) Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated witih organic brain syndrome. J Clin Psychiatry 40: 411–419PubMedGoogle Scholar
  71. 71.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W (1993) A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 13: 25–40PubMedCrossRefGoogle Scholar
  72. 72.
    Kurz M, Hummer M, Oberbauer H, Fleischhacker WW (1995) Extrapyramidal side effects of Clozapine and haloperidol. Psychopharmacology 118: 52–56PubMedCrossRefGoogle Scholar
  73. 73.
    Musser WS, Akil M (1996) Clozapine as a treatment for psychosis in Parkinson’s disease: a review. J Neuropsychiatry Clin Neurosci 8: 1–9PubMedGoogle Scholar
  74. 74.
    Wolters EC, Jansen ENH, Tuynman-Qua HG, Bergmans PLM (1996) Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease. Neurology 47: 1085–1087PubMedCrossRefGoogle Scholar
  75. 75.
    Knesevich JW, Martin RL, Berg L, Danziger W (1983) Preliminary report on affective symptoms in the early stages of senile dementia of the Alzheimer type. Am J Psychiatry 140: 233–235PubMedGoogle Scholar
  76. 76.
    Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–61PubMedCrossRefGoogle Scholar
  77. 77.
    American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Press, Washington DCGoogle Scholar
  78. 78.
    Spitzer RL, Williams JBW, Gibbon M, First MB (1988) Structured clinical interview guide for DSM-III-R. New York State Psychiatric Institute, Biometrics Research Department, New YorkGoogle Scholar
  79. 79.
    Burke WJ, Rubin EH, Morris JC, Berg L (1988) Symptoms of “depression” in dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 2: 356–362PubMedCrossRefGoogle Scholar
  80. 80.
    Yesavage JA, Brink TL, Rose TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17: 37–49CrossRefGoogle Scholar
  81. 81.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561–571PubMedCrossRefGoogle Scholar
  82. 82.
    Zung WWK (1965) A self-rating depression scale. Arch Gen Psychiatry 12: 56–65CrossRefGoogle Scholar
  83. 83.
    Burke WJ, Houston MJ, Boust SJ, Roccaforte WH (1989) Use of the Geriatric Depression Scale in dementia of the Alzheimer type. J Am Geriatr Soc 37: 856–860PubMedGoogle Scholar
  84. 84.
    Feher EP, Larrabee GJ, Crook TH (1992) Factors attenuating the validity of the Geriatric Depression Scale in a dementia population. J Am Geriatr Soc 40: 906–909PubMedGoogle Scholar
  85. 85.
    Alexopoulos GS, Abrams RC, Young RC, Shamoian CA (1988) Cornell scale for depression in dementia. Biol Psychiatry 23: 271–284PubMedCrossRefGoogle Scholar
  86. 86.
    Logsdon RG, Teri L (1995) Depression in Alzheimer’s disease patients: caregivers as surrogate reporters. J Am Geriatr Soc 43: 150–155PubMedGoogle Scholar
  87. 87.
    Mackenzie TB, Robiner WN, Knopman DS (1989) Differences between patient and family assessments of depression in Alzheimer’s disease. Am J Psychiatry 146: 1174–1178PubMedGoogle Scholar
  88. 88.
    Cohen D, Eisdorfer C (1988) Depression in famiy members caring for a relative with Alzheimer’s disease. J Am Geriatr Soc 36: 885–889PubMedGoogle Scholar
  89. 89.
    Teri L, Wagner AW (1991) Assessment of depresion in patients with Alzheimer’s disease: concordance among informants. Psychol Aging 6: 280–285PubMedCrossRefGoogle Scholar
  90. 90.
    Weiner MF, Edland SD, Luszczynska H (1994) Prevalence and incidence of major depression in Alzheimer’s disease. Am J Psychiatry 151: 1006–1009PubMedGoogle Scholar
  91. 91.
    Cummings JL (1988) Depression in vascular dementia. Hillside J Clin Psychiatry 10: 209–231PubMedGoogle Scholar
  92. 92.
    Erkinjuntti T (1987) Types of multi-infarct dementia. Acta Neurol Scand 75: 391–399PubMedCrossRefGoogle Scholar
  93. 93.
    Huber SJ, Shuttleworth EC, Paulson GW (1986) Dementia in Parkinson’s disease. Arch Neurol 43: 987–990PubMedCrossRefGoogle Scholar
  94. 94.
    Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, Goldstein M (1979) Dementia in Parkinson disease. Ann Neurol 6: 355–359PubMedCrossRefGoogle Scholar
  95. 95.
    Menza MA, Cocchiola J, Golbe LI (1995) Psychiatric symptoms in progressive supranuclear palsy. Psychosomatics 36: 550–554PubMedCrossRefGoogle Scholar
  96. 96.
    Pujol J, Leal S, Fluvia X, Conde C (1989) Psychiatric aspects of normal-pressure hydrocephalus: a report of five cases. Br J Psychiatry 154[Suppl 4]: 77–80Google Scholar
  97. 97.
    Brown RG, MacCarthy B (1990) Psychiatric morbidity in patients with Parkinson’s disease. Psychol Med 20: 77–87PubMedCrossRefGoogle Scholar
  98. 98.
    Brown RG, MacCarthy B, Gotham AM, Der GJ, Marsden CD (1988) Depression and disability in Parkinson’s disease: a follow-up study of 132 cases. Psychol Med 18: 49–55PubMedCrossRefGoogle Scholar
  99. 99.
    Gotham AM, Brown RG, Marsden CD (1986) Depression in Parkinson’s disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49: 381–389PubMedCrossRefGoogle Scholar
  100. 100.
    Huber SJ, Paulson GW, Shuttleworth EC (1988) Depression in Parkinson’s disease. Neuropsychiatry Neuropsychol Behav Neurol 1: 47–51Google Scholar
  101. 101.
    Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber, S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529–1534PubMedCrossRefGoogle Scholar
  102. 102.
    Fischer P, Simanyi M, Danielczyk W (1990) Depression in dementia of the Alzheimer type and in multi-infarct dementia. Am J Psychiatry 147: 1484–1487PubMedGoogle Scholar
  103. 103.
    Pearson JL, Teri L, Reifler BV, Raskind MA (1989) Functional status and cognitive impairment in Alzheimer’s patients with and without depression. J Am Geriatr Soc 37: 1117–1121PubMedGoogle Scholar
  104. 104.
    Breen AR, Larson EB, Reifler BV, Vitaliano PP, Lawrence GL (1984) Cognitive performance and functional competence in coexisting dementia and depression. J Am Geriatr Soc 32: 132–137PubMedGoogle Scholar
  105. 105.
    Rovner BW, Broadhead J, Spencer M, Carson K, Folstein MF (1989) Depression and Alzheimer’s disease. Am J Psychiatry 146: 350–353PubMedGoogle Scholar
  106. 106.
    Fitz AG, Teri L (1994) Depression, cognition, and functional ability in patients with Alzheimer’s disease. J Am Geriatr Soc 42: 186–191PubMedGoogle Scholar
  107. 107.
    Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG (1990) Depression in Parkinson’s disease. J Nerv Ment Disord 178: 27–31CrossRefGoogle Scholar
  108. 108.
    Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus ceruleus in senile dementia of the Alzheimer type and in Parkinson’s disease with and without dementia and depression. J Comp Neurol 287: 373–392PubMedCrossRefGoogle Scholar
  109. 109.
    Forstl H, Levy R, Burns A, Luthert P, Cairns N (1994) Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer’s disease — a hypothesis. Pharmacopsychiatry 27: 11–15PubMedCrossRefGoogle Scholar
  110. 110.
    Mayeux R, Stern Y, Sano M, Williams JB, Cote LJ (1988) The relationship of serotonin to depression in Parkinson’s disease. Mov Disord 3: 237–244PubMedCrossRefGoogle Scholar
  111. 111.
    Zubenko GS, Moossy J (1988) Major depression in primary dementia: clinical and neuropathologic correlates. Arch Neurol 45: 1182–1186PubMedCrossRefGoogle Scholar
  112. 112.
    Davis KL, Hollander E, Davidson M, Davis M, Mohs RC, Horvath TB (1987) Induction of depression with oxotremorine in patients with Alzheimer’s disease. Am J Psychiatry 144: 468–471PubMedGoogle Scholar
  113. 113.
    Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannais RF, Wagner HN Jr, Robinson RG (1990) Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Ann Neurol 28: 57–64PubMedCrossRefGoogle Scholar
  114. 114.
    Mayberg HS, Starkstein SE, Peyser CE, Brandt J, Dannals RF, Folstein SE (1992) Paralimbic frontal lobe hypometabolism in depression associated with Huntington’s disease. Neurology 42: 1791–1797PubMedCrossRefGoogle Scholar
  115. 115.
    Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C (1995) Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and positron emission tomographic findings. Arch Neurol 52: 773–780PubMedCrossRefGoogle Scholar
  116. 116.
    Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, McLean P (1989) Doubleblind trial of imipramine in Alzheimer’s disease patients with and without depression. Am J Psychiatry 146: 45–49PubMedGoogle Scholar
  117. 117.
    Fuchs A, Hehnke U, Erhart C, Schell C, Pramshohler B, Danninger B, Schautzer F (1993) Video rating analysis of effect of maprotiline in patients with dementia and depression. Pharmacopsychiatry 26: 37–41PubMedCrossRefGoogle Scholar
  118. 118.
    Nyth AL, Gottfries CG (1990) The clinical efficacy of Citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br J Psychiatry 157: 894–901PubMedCrossRefGoogle Scholar
  119. 119.
    Olafsson K, Jorgensen S, Jensen HV, Bille A, Arup P, Andersen J (1992) Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study. Acta Psychiatr Scand 85: 453–456PubMedCrossRefGoogle Scholar
  120. 120.
    Dewan VK, Burke WJ, Roccaforte WH (1995) Selective serotonin reuptake inhibitors for treatment of depression and psychosis in dementia. In: New research and program abstracts: 1995 annual meeting. American Psychiatric Association, Washington DCGoogle Scholar
  121. 121.
    Volicer L, Rheaume Y, Cyr D (1994) Treatment of depression in advanced Alzheimer’s disease using sertraline. J Geriatr Psychiatry Neurol 7: 227–229PubMedGoogle Scholar
  122. 122.
    Postma JU, Vranesic D (1985) Moclobemide in the treatment of depression in demented geriatric patients. Acta Ther 11: 1–4Google Scholar
  123. 123.
    Tariot PN, Cohen RM, Sunderland T, Newhouse PA, Yount D, Mellow AM, Weingartner H, Mueller EA, Murphy DL (1987) 1-Deprenyl in Alzheimer’s disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition. Arch Gen Psychiatry 44: 427–433PubMedCrossRefGoogle Scholar
  124. 124.
    Flint AJ (1994) Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 151: 640–649PubMedGoogle Scholar
  125. 125.
    Cassem EH (1990) Depression and anxiety secondary to medical illness. Psychiatr Clin North Am 13: 597–612PubMedGoogle Scholar
  126. 126.
    Alexopoulos GS (1990) Anxiety-depression syndromes in old age. Int J Geriatr Psychiatry 5: 351–353CrossRefGoogle Scholar
  127. 127.
    Lindesay J, Briggs K, Murphy E (1989) The Guy’s/Age Concern Survey: prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry 155: 317–329PubMedGoogle Scholar
  128. 128.
    Regier DA, Boyd JH, Burke JD, Jr, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ (1988) One-month prevelance of mental disorders in the United States: based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 45: 977–986PubMedCrossRefGoogle Scholar
  129. 129.
    Wands K, Merskey H, Hachinski VC, Fisman M, Fox H, Boniferro M (1990) A questionnaire investigation of anxiety and depression in early dementia. J Am Geriatr Soc 38: 535–538PubMedGoogle Scholar
  130. 130.
    Shader RI, Greenblatt DJ (1982) Management of anxiety in the elderly: the balance between therapeutic and adverse effects. J Clin Psychiatry 43[Suppl]: 8–18PubMedGoogle Scholar
  131. 131.
    Cohen-Mansfield J, Billig N (1986) Agitated behaviors in the elderly. I. A conceptual review. J Am Geriatr Soc 34: 711–721PubMedGoogle Scholar
  132. 132.
    Cohen-Mansfield J, Marx MS, Rosenthal AS (1989) A description of agitation in a nursing home. J Gerontol 44: M77–M84PubMedCrossRefGoogle Scholar
  133. 133.
    Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D (1986) The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143: 35–39PubMedGoogle Scholar
  134. 134.
    Ryden MB, Bossenmaier M, McLachlan C (1991) Aggressive behavior in cognitively impaired nursing home residents. Res Nursing Health 14: 87–95CrossRefGoogle Scholar
  135. 135.
    Devanand DP, Brockington CD, Moody BJ, Brown RP, Mayeux R, Endicott J, Sackeim HA (1992) Behavioral syndromes in Alzheimer’s disease. Int Psychogeriatr 4[Suppl 2]: 161–184PubMedGoogle Scholar
  136. 136.
    Ryden M (1988) Aggressive behavior in persons with dementia who live in the community. Alzheimer Dis Assoc Disord 2: 342–355PubMedCrossRefGoogle Scholar
  137. 137.
    Lachs MS, Becker M, Siega AP, Miller RL, Tinetti ME (1992) Delusions and behavioral disturbances in cognitively impaired elderly persons. J Am Geriatr Soc 40: 768–773PubMedGoogle Scholar
  138. 138.
    Mann AH, Graham N, Ashby D (1984) Psychiatric illness in residential homes for the elderly: a survey in one London borough. Age Ageing 13: 257–265PubMedCrossRefGoogle Scholar
  139. 139.
    Aronson MK, Post DC, Guastadisegni P (1993) Dementia, agitation, and care in the nursing home. J Am Geriatr Soc 41: 507–512PubMedGoogle Scholar
  140. 140.
    Chui HC, Lyness SA, Sobel E, Schneider LS (1994) Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer’s disease. Arch Neurol 51: 676–681PubMedCrossRefGoogle Scholar
  141. 141.
    Gold DP, Reis MF, Markiewicx D, Andres D (1995) When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia. J Am Geriatr Soc 43: 10–16PubMedGoogle Scholar
  142. 142.
    Coyne AC, Reichmann WE, Berbig RMT (1993) The relationship between dementia and elder abuse. Am J Psychiatry 150: 643–646PubMedGoogle Scholar
  143. 143.
    Bridges-Parlet S, Knopman D, Thompson T (1994) A descriptive study of physically aggressive behavior in dementia by direct observation. J Am Geriatr Soc 42: 192–197PubMedGoogle Scholar
  144. 144.
    Nilsson K, Palmstierna T, Wistedt B (1988) Aggressive behavior in hospitalized psychogeriatric patients. Acta Psychiatr Scand 78: 172–175PubMedCrossRefGoogle Scholar
  145. 145.
    Burnside IM (1980) Wandering behavior. In: Burnside IM (ed) Psychosocial nursing care of the aged, 2nd edn. McGraw-Hill, New YorkGoogle Scholar
  146. 146.
    Rabins PV, Mace NL, Lucas MJ (1982) The impact of dementia on the family. JAMA 148: 333–335CrossRefGoogle Scholar
  147. 147.
    Ryan JP, McGowan J, McCaffrey N, Ryan GT, Zandi T, Brannigan GG (1995) Graphomotor Perseveration and wandering in Alzheimer’s disease. J Geriatr Psychiatry Neurol 8: 209–212PubMedGoogle Scholar
  148. 148.
    Okawa M, Mishima K, Hishikawa Y, Hozumi S, Hori H, Takahashi K (1991) Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep 14: 478–485PubMedGoogle Scholar
  149. 149.
    Snyder LH, Rupprecht P, Pyrek J (1979) Wandering. Gerontologist 18: 272CrossRefGoogle Scholar
  150. 150.
    Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257: 1492–1495PubMedCrossRefGoogle Scholar
  151. 151.
    Hewawasam L (1996) Floor patterns limit wandering of people with Alzheimer’s. Nursing Times 92: 41–44PubMedGoogle Scholar
  152. 152.
    Hussian RA, Brown DC (1987) Use of two-dimensional grid patterns to limit hazardous ambulation in demented patients. J Gerontol 42: 558–560PubMedCrossRefGoogle Scholar
  153. 153.
    Arno S, Frank DI (1994) A group for “wandering” institutionalized clients with primary degenerative dementia. Perspect Psychiatr Care 30: 13–16PubMedCrossRefGoogle Scholar
  154. 154.
    Michel K, Kolakowska T (1981) A survey of prescribing psychotropic drugs in two psychiatric hospital. Br J Psychiatry 138: 217–221PubMedCrossRefGoogle Scholar
  155. 155.
    Prien Y, Haber PA, Caffey EMJ (1975) The use of psycho active drugs in elderly patients with psychiatric disorders: survey conducted in twelve Veterans Administration hospitals. J Am Geriatr Soc 23: 104–112PubMedGoogle Scholar
  156. 156.
    Rada RT, Kellner R (1976) Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome. J Am Geriatr Soc 24: 105–107PubMedGoogle Scholar
  157. 157.
    Petrie WM, Ban TA, Berney S, Fujimori M, Guy W, Ragheb M, Wilson WH, Schaffer JD (1982) Loxapine in psychogeriatrics: a placebo-and standard-controlled clinical investigation. J Clin Psychopharmacol 2: 122–126PubMedCrossRefGoogle Scholar
  158. 158.
    Chesrow EJ, Kaplitz SE, Vetra H, Breme JT, Marquardt GH (1965) Blind study of oxazepam in the management of geriatric patients with behavioral problems. Clin Med 72: 1001–1005Google Scholar
  159. 159.
    DeLemos GP, Clement WR, Nickels E (1965) Effect of diazepam suspension in geriatric patients hospitalized for psychiatric illnesses. J Am Geriatr Soc 13: 355–359PubMedGoogle Scholar
  160. 160.
    Beber CR (1965) Management of behavior in the institutionalized aged. Dis Nerv Syst 26: 591–595PubMedGoogle Scholar
  161. 161.
    Coccaro EF, Kramer E, Zemishlany Z, Thorne A, Rice CM, Giordani B, Duwi K, Patel BM, Torres J, Nora R, Neufeld R, Mohs RC, Davis KL (1990) Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am J Psychiatry 147: 1640–1645PubMedGoogle Scholar
  162. 162.
    Tariot PN, Erb R, Leibovici A, Podgorski CA, Cox C, Asnis J, Kolassa J, Irvine C (1994) Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 42: 1160–1166PubMedGoogle Scholar
  163. 163.
    Chambers CA, Bain J, Rosbottom R, Ballinger BR, McLaren S (1982) Carbamazepine in senile dementia and over activity-a placebo controlled double blind trial. IRCS Med Sci 19: 505–506Google Scholar
  164. 164.
    Gleason R, Schneider LS (1990) Carbamazepine treatment of agitation in Alzheimer’s outpatients refractory to neuroleptics. J Clin Psychiatry 51: 115–118PubMedGoogle Scholar
  165. 165.
    Patterson JF (1987) Carbamazepine for assaultive patients with organic brain disease. Psychosomatics 28: 579–581PubMedCrossRefGoogle Scholar
  166. 166.
    Patterson JF (1988) A preliminary study of carbamazepine in the treatment of assaultive patients with dementia. J Geriatry Psychiatry Neurol 1: 21–23CrossRefGoogle Scholar
  167. 167.
    Lott AD, McElroy SL, Keys MA (1995) Valproate in the treatment of behavioral agitation in elderly patients with dementia. J Neuropsychiatry Clin Neurosci 7: 314–319PubMedGoogle Scholar
  168. 168.
    Roy A, Linnoila M (1988) Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand 78: 529–535PubMedCrossRefGoogle Scholar
  169. 169.
    van Praag HM (1991) Serotonergic dysfunction and aggression control. Psychol Med 21: 15–19PubMedCrossRefGoogle Scholar
  170. 170.
    Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL (1989) Hyperresponsitvity to the serotonin agonist m-chlorphenylpiperazine in Alzheimer’s disease. Arch Gen Psychiatry 46: 542–549PubMedCrossRefGoogle Scholar
  171. 171.
    Houlihan BJ, Mulsant DJ, Sweet RA, Rifai AH, Pasternak R, Rosen J, Zubenko GS (1994) A naturalistic study of trazodone in the treatment of behavioral complications of dementia. Am J Geriatr Psychiatry 2: 78–85PubMedCrossRefGoogle Scholar
  172. 172.
    Lebert F, Pasquier F, Petit H (1994) Behavioral effects of trazodone in Alzheimer’s disease. J Clin Psychiatry 55: 536–538PubMedGoogle Scholar
  173. 173.
    Sultzer DL, Gray KF, Gunay I, Berisford MA, Mahler ME (1997) A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 5: 60–69PubMedGoogle Scholar
  174. 174.
    Dehlin O, Hedenrud B, Jansson P, Norgard J (1985) A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. Acta Psychiatr Scand 71: 190–196PubMedCrossRefGoogle Scholar
  175. 175.
    Geldmacher DS, Waldman AJ, Doty L, Heilman KM (1994) Fluoxetine in dementia of the Alzheimer’s type: prominent adverse effects and failure to improve cognition. J Clin Psychiatry 55: 161PubMedGoogle Scholar
  176. 176.
    Goad DL, Davis CM, Liem P, Fuselier CC, McCormack JR, Olsen KM (1991) The use of Selegiline in Alzheimer’s patients with behavior problems. J Clin Psychiatry 52: 342–345PubMedGoogle Scholar
  177. 177.
    Schneider LS, Pollock VE, Zemansky MF, Gleason RP, Palmer R, Sloane RB (1991) A pilot study of low dose 1-deprenyl in Alzheimer’s disease. J Geriatr Psychiatry Neurol 4: 143–148PubMedCrossRefGoogle Scholar
  178. 178.
    Burke WJ, Roccaforte WH, Wengel SP, Bayer BL, Ranno AE, Willcockson NK (1993) 1-Deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial. J Am Geriatr Soc 41: 1219–1225PubMedGoogle Scholar
  179. 179.
    Hermann N, Eryavec G (1993) Buspirone in the management of agitation and aggression associated with dementia. Am J Geriatr Psychiatr 1: 249–253CrossRefGoogle Scholar
  180. 180.
    Sakauye KM, Camp CJ, Ford PA (1993) Effects of buspirone on agitation associated with dementia. Am J Geriatr Psychiatry 1: 82–84CrossRefGoogle Scholar
  181. 181.
    Williams KH, Goldstein C (1979) Cognitive and affective response to lithium in patients with organic brain syndrome. Am J Psychiatry 136: 800–803PubMedGoogle Scholar
  182. 182.
    Greendyke RM, Kanter DR (1986) Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double blind study. J Clin Psychiatry 47: 423–426PubMedGoogle Scholar
  183. 183.
    Greendyke RM, Kanter DR, Schuster DB, Verstreate S, Wootton J (1986) Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study. J Nerv Ment Dis 174: 290–294PubMedCrossRefGoogle Scholar
  184. 184.
    Kaufer DI, Cummings JL, Christine D (1996) Effect of tacrine on behavioral symptoms in Alzheimer’s disease: an open-label study. J Geriatr Psychiatry Neurol 9: 1–6PubMedGoogle Scholar
  185. 185.
    Cummings JL, Petry S, Dian L, Shapira J, Hill MA (1990) Organic personality disorder in dementia syndromes: an inventory approach. J Neuropsychiatr Clin Neurosci 2: 261–267Google Scholar
  186. 186.
    Burns A, Folstein S, Brandt J, Folstein M (1990) Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nerv Mental Dis 178: 20–26CrossRefGoogle Scholar
  187. 187.
    Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4: 134–139PubMedGoogle Scholar
  188. 188.
    Bozzola FG, Gorelick PB, Freels S (1992) Personality changes in Alzheimer’s disease. Arch Neurol 49: 297–300PubMedCrossRefGoogle Scholar
  189. 189.
    Reichman WE, Coyne AC, Amirneni S, Molino B Jr, Egan S (1996) Negative symptoms in Alzheimer’s disease. Am J Psychiatry 153: 424–426PubMedGoogle Scholar
  190. 190.
    Rubin EH, Morris JC, Berg L (1987) The progression of personality changes in senile dementia of the Alzheimer’s type. J Am Geriatr Soc 35: 721–725PubMedGoogle Scholar
  191. 191.
    Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3: 243–254PubMedGoogle Scholar
  192. 192.
    Marin RS, Firinciogullari S, Biedrzycki RC (1993) The sources of convergence between measures of apathy and depression. J Affect Disord 28: 117–124PubMedCrossRefGoogle Scholar
  193. 193.
    Cummings JL (1995) Anatomic and behavioral aspects of frontal-subcortical circuits. Ann NY Acad Sci 769: 1–13PubMedCrossRefGoogle Scholar
  194. 194.
    Cummings JL (1994) Vascular subcortical dementias: clinical aspects. Dementia 5: 177–180PubMedGoogle Scholar
  195. 195.
    Lilly R, Cummings JL, Benson DF, Frankel M (1983) The human Kluver-Bucy syndrome. Neurology 33: 1141–1145PubMedCrossRefGoogle Scholar
  196. 196.
    Cummings JL, Benson DF (1987) The role of the nucleus basalis of Meynert in dementia: review and reconsideration. Alzheimer Dis Assoc Disord 1: 128–145PubMedCrossRefGoogle Scholar
  197. 197.
    Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237–1239PubMedCrossRefGoogle Scholar
  198. 198.
    Klüver H, Bucy P (1937) “Psychic blindness” and other symptoms following bilateral temporal lobectomy in rhesus monkeys. Am J Physiol 119: 352Google Scholar
  199. 199.
    Terzain H, Ore G (1955) Syndrome of Klüver and Bucy. Neurology 5: 373–380CrossRefGoogle Scholar
  200. 200.
    Sourander P, Sjögren H (1970) The concept of Alzheimer’s disease and its clinical implications. In: Wolstenholme G, O’Connor M (eds) Alzheimer’s disease and related conditions. Churchill Livingstone, London, pp 11–31Google Scholar
  201. 201.
    Cummings JL, Duchen L (1981) Kluver-Bucy syndrome in Pick disease: clinical and pathologic conditions. Neurology 31: 1415–1422PubMedCrossRefGoogle Scholar
  202. 202.
    Forstl H, Burns A, Levy R, Cairns N, Luthert P, Lanto P (1993) Neuropathological correlates of behavioural disturbance in confirmed Alzheimer’s disease. Br J Psychiatry 163: 364–368PubMedCrossRefGoogle Scholar
  203. 203.
    Janati A (1985) Kluver-Bucy syndrome in Huntington’s chorea. J Nerv Ment Dis 173: 632–635PubMedCrossRefGoogle Scholar
  204. 204.
    Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B (1995) Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 7: 23–30PubMedGoogle Scholar
  205. 205.
    Leo RJ, Kim KY (1995) Clomipramine treatment of paraphilias in elderly demented patients. J Geriatr Psychiatry Neurol 8: 123–124PubMedGoogle Scholar
  206. 206.
    Tiller JWG, Dakis JA, Shaw JM (1988) Short-term buspirone treatment in disinhibition with dementia. Lancet 2(8609): 510 (letter)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • S. T. Chen
  • J. L. Cummings

There are no affiliations available

Personalised recommendations